非小细胞肺癌细胞免疫疗法的进展:在树突细胞,T细胞和NK细胞疫苗方面的进展
Mirza Masroor Ali Beg1, Mohammad Aslam2, Asma Ayaz3
1Faculty of Medicine, Ala-Too International University, Bishkek 720048, Kyrgyzstan.
Cells
|September 26, 2025
概括
细胞免疫疗法,如树突细胞 (DC) 疫苗,T细胞和自然杀手 (NK) 细胞疗法,对非小细胞肺癌 (NSCLC) 有望. 与其他治疗方法的结合提高了疗效,代表了NSCLC治疗的不断发展的前沿.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
背景情况:
- 细胞免疫疗法已经成为非小细胞肺癌 (NSCLC) 的关键策略.
- 树突细胞 (DC) 疫苗,T细胞疫苗和自然杀手 (NK) 细胞疗法提供了不同的机制和临床潜力.
- 目前的研究重点是优化这些疗法,以改善患者的治疗结果.
研究的目的:
- 审查目前NSCLC细胞免疫疗法的现状.
- 突出DC,T细胞和NK细胞疗法的机制,临床潜力和最近的创新.
- 讨论组合策略的作用和NSCLC治疗的未来方向.
主要方法:
- 对NSCLC细胞免疫疗法的现有文献的审查.
- 对DC疫苗,T细胞疫苗和NK细胞疗法的临床试验数据的分析.
- 综合了最近的进展,包括个性化的方法和组合策略.
主要成果:
- DC疫苗显示出良好的安全性,但单一疗法的有效性有限;组合改善了结果.
- T细胞疫苗的结果不尽相同,一些组合改善了生存率.
- NK细胞疗法证明了可行性,工程化CAR-NK细胞和组合策略显示出有希望.
- 创新包括带有新抗原的DC,mRNA疫苗和工程NK细胞.
结论:
- 细胞免疫疗法,包括DC,T细胞和NK细胞疗法,是NSCLC的多功能和不断发展的治疗前沿.
- 结合检查点抑制剂或化疗的结合策略显著增强免疫激活和生存.
- 目前正在进行的研究旨在优化输送平台,患者选择和治疗组合,以获得NSCLC的最大益处.
相关概念视频
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
01:30Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972
01:27Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K